Month: April 2021

GW’s ground-breaking medicines development programme recognised for outstanding achievement in innovation with UK’s highest official award for British business LONDON, April 29, 2021 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), a world leader in discovering, developing and commercialising regulatory approved cannabis-based medicines, announces that it has received the Queen’s Award for Enterprise 2021 in the Innovation category, recognising GW’s innovative and ground-breaking work to harness cannabinoid science to create the world’s first regulatory approved, prescription cannabis-based medicines. Since its inception in 1998, GW has successfully navigated significant barriers to enable the development, manufacture and commercialisation of regulatory approved cannabis-based medicines,...

BOSTON, April 28, 2021 (GLOBE NEWSWIRE) — Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced that Richard Peters, M.D., Ph.D., President and Chief Executive Officer, will present at the 2021 B. Riley Securities’ Neuroscience Conference. The presentation will be available on-demand via the conference portal and through the Company’s website at www.yumanity.com/events beginning at 2:30 p.m. EDT, April 29. About Yumanity TherapeuticsYumanity Therapeutics is a clinical-stage biopharmaceutical company dedicated to accelerating the revolution in the treatment of neurodegenerative diseases through its scientific foundation and drug discovery platform. The Company’s most...

FRISCO, TEXAS, April 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Verde Bio Holdings, Inc. (OTC: VBHI), filed a 253(g) Supplement with the U.S. Securities & Exchange Commission on Wednesday April 28, 2021 which erroneously stated that the number of shares being offered under the Regulation A offering was being increased to 10,000,000,000 shares. A subsequent 253(g) Supplement was filed correcting this error.  The correct number of shares being offered is one billion (1,000,000,000) at the price of $0.01 per share pursuant the Regulation A offering.  Once all of the one billion shares are sold, the offering will close.  Verde Bio Holdings, Inc. regrets any confusion which this erroneous filing may have caused.  “With the recent announcement of settlement of all debt, the Company is moving forward with a strong balance...

ERYTECH Reports Cash Balance at End of Q1 2021 and Announces the Details of its 2021 Q1 conference call Publication of Q1 2021 results on 4 May 2021 after market closeLyon (France) and Cambridge, MA (U.S.), April 29, 2021 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced its cash position at the end of the first quarter 2021 and that it will host its 2021 first quarter conference call and webcast on Wednesday, May 5, 2021, at 2:30 PM CEST/8:30 AM EST to discuss operational highlights. Update on Q1 2021 Cash position As of March 31, 2021, ERYTECH had cash and cash equivalents totaling €37.4 million (approximately $43.9 million), compared with €44.4 million on December 31, 2020....

VANCOUVER, British Columbia, April 28, 2021 (GLOBE NEWSWIRE) — Imperial Metals Corporation (the “Company”) (TSX:III) reports Red Chris metal production (100%) for the first quarter of 2021 was 15.9 million pounds copper and 15,850 ounces gold, compared to 17.2 million pounds copper and 16,251 ounces gold produced during the fourth quarter of 2020. In February, a major power outage during an extreme winter weather event caused some mill infrastructure to freeze. The freezing conditions resulted in damage to a regrind mill and adversely impacted recovery during the period. Imperial’s 30% portion of the first quarter production was 4.8 million pounds copper and 4,755 ounces gold. The Red Chris Mineral Resource update, which was released on March 30, 2021, is a key input into the Pre-Feasibility Study (“PFS”) being prepared on the...

NOTABLE ITEMS FOR THE QUARTER INCLUDE:DILUTED EARNINGS PER SHARE INCREASED OVER 46% TO $0.38 AS COMPARED TO $0.26 FOR THE TRAILING QUARTER, AND OVER 280% COMPARED TO $0.10 FOR THE FIRST QUARTER OF 2020. NET INTEREST INCOME INCREASED $3.1 MILLION, OR 8.5%, OVER THE TRAILING QUARTER, AND $10.2 MILLION, OR 34.2%, COMPARED TO THE FIRST QUARTER OF 2020. NET INTEREST MARGIN INCREASED 27 BASIS POINTS TO 3.10% AS COMPARED TO 2.83% FOR THE TRAILING QUARTER, AND 53 BASIS POINTS AS COMPARED TO 2.57% FOR THE FIRST QUARTER OF 2020. LOANS HELD-FOR-INVESTMENT, NET, INCREASED $109.8 MILLION, OR 11.5% ANNUALIZED. DEPOSITS, EXCLUDING BROKERED, INCREASED $25.2 MILLION, OR 2.6%, ANNUALIZED. THE COMPANY ADOPTED THE CURRENT EXPECTED CREDIT LOSSES (“CECL”) ACCOUNTING STANDARD AS OF JANUARY 1, 2021. INCREASED QUARTERLY CASH DIVIDEND BY 18.2% TO $0.13 PER SHARE...

GUADALAJARA, Mexico, April 28, 2021 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacifico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces the following resolutions adopted at the Annual General Ordinary and Extraordinary Shareholders’ Meetings held on April 27, 2021, with a quorum of 87.2% and 90.2%, respectively: ANNUAL GENERAL ORDINARY SHAREHOLDERS’ MEETING RESOLUTIONS I.     In accordance with Article 28, Section IV of the Mexican Securities Market Law, the following were approved:The Chief Executive Officer’s report regarding the results of operations for the fiscal year ended December 31, 2020, in accordance with Article 44, Section XI of the Mexican Securities Market Law and Article 172 of the Mexican General Corporations Law, together with the external auditor’s report, with respect to the Company...

IRVING, Texas, April 28, 2021 (GLOBE NEWSWIRE) — CorePoint Lodging Inc. (NYSE: CPLG) (“CorePoint” or the “Company”) today announced that the Company plans to report financial results for the first quarter of 2021 after the market closes on Thursday, May 6, 2021. The Company will also host a conference call for investors and other interested parties to discuss its results beginning at 5:00 p.m. Eastern Time that day. The call may be accessed by dialing (888) 330-2042 or (365) 605-5061 and entering the passcode 1068176. Participants may also access the call via webcast by visiting www.corepoint.com/investors. The replay of the call will be available from approximately 8:00 p.m. Eastern Time on May 6, 2021 through 8:00 p.m. Eastern Time on May 13, 2021. To access the replay, the dial-in number is (800) 770-2030 and the passcode is...

LEAWOOD, Kan., April 28, 2021 (GLOBE NEWSWIRE) — Euronet Worldwide, Inc. (“Euronet” or the “Company”) (NASDAQ: EEFT), a leading electronic payments provider, reports first quarter 2021 financial results. Euronet reports the following consolidated results for the first quarter 2021 compared with the same period of 2020:Revenues of $652.7 million, a 12% increase from $583.9 million (7% increase on a constant currency1 basis).Operating income of $10.4 million, a 67% decrease from $31.6 million (70% decrease on a constant currency basis).Adjusted EBITDA2 of $52.2 million, a 24% decrease from $68.7 million (28% decrease on a constant currency basis).Net loss attributable to Euronet of ($8.7 million) or ($0.16) diluted loss per share, compared with net income of $1.9 million or $0.04 diluted earnings per share.Adjusted earnings...

ATLANTA, April 28, 2021 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) today announced the pricing of its initial public offering of 38,236,000 shares of its common stock at an initial public offering price of $12.00 per share. The shares are expected to begin trading on the Nasdaq Global Select Market on April 29, 2021 under the ticker symbol “AVAH.” Aveanna has also granted the underwriters a 30-day option to purchase up to an additional 5,735,400 shares of its common stock. The offering is expected to close on May 3, 2021, subject to customary closing conditions. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse are acting as joint lead book-running managers, and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets and Truist Securities are acting as book-running managers for...